[1]
“Prospective Validation of a Genomic Assay in Breast Cancer: The 70-gene MammaPrint Assay and the MINDACT Trial”, ama, vol. 48, no. 1, pp. 18–34, Jun. 2019, doi: 10.5644/ama2006-124.239.